Intracellular analysis of interleukin-2 induction provides direct evidence at the single cell level of differential coactivation requirements for CD45RA+ and CD45RO+ T cell subsets

Journal of Interferon and Cytokine Research

Volumn 19, Issue 7, 1999, Pages 769-779

  Woodside, Darren G ^b   Long, Dorothy A ^a   McIntyre, Bradley W ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD45 ANTIGEN; DIPEPTIDYL PEPTIDASE IV; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; T LYMPHOCYTE RECEPTOR;

ARTICLE; BINDING AFFINITY; CELL LEVEL; CELL PROLIFERATION; CROSS LINKING; CYTOKINE PRODUCTION; DISSOCIATION CONSTANT; HUMAN; HUMAN CELL; MEMORY CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; STAINING; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

ANTIGENS, CD45; HUMANS; IMMUNOLOGIC MEMORY; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; REFERENCE VALUES; SOLUBILITY; T-LYMPHOCYTE SUBSETS;

EID: 0032814067     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/107999099313622     Document Type: Article

References (52)

1. SHAW, A.S., and DUSTIN, M.L. (1997). Making the T cell receptor go the distance: a topological view of T cell activation. Immunity 6, 361-369.
2. MUELLER, D.L., JENKINS, M.K., and SCHWARTZ, R.H. (1989). Clonal expansion versus functional clonal inactivation: a costimulatory signaling pathway determines the outcome of T cell antigen receptor occupancy. Annu. Rev. Immunol. 7, 445-480.
3. GRAY, D. (1993). Immunoiogical memory. Annu. Rev. Immunol. 11, 49-77.
4. FLEISCHER, B. (1987). A novel pathway of human T cell activation via a 103 kD T cell activation antigen. J. Immunol, 138, 1346-1350.
5. DANG, N.H., TORIMOTIO, Y., DEUSCH, K., SCHLOSSMAN, S.F., and MORIMOTO, C. (1990). Comitogenic effect of solid phase immobilized anti-1F7 on human CD4 T cell activation via CD3 and CD2 pathways. J. Immunol. 144, 4092-4100.
6. DANG, N.H., HAFLER, D., SCHLOSSMAN, S.F., and BREITMEYER, J. (1990). FcR-mediated cross-linking of Tal (CDw26) induces human T lymphocyte activation. Cell. Immunol. 125, 42-57.
7. BEDNARCZYK, J.L., CARROLL, S.M., MARIN. C., and McINTYRE, B.W. (1991). Triggering of the proteinase dipeptidyl peptidase IV (CD26) amplifies human T lymphocyte proliferation. J. Cell. Biochem, 46, 206-218.
8. THOMPSON, C.B., LINDSTEN, T., LEDBETTER, J.A., KUNKEL, S.L., YOUNG, H.A., EMERSON, S.G., LEIDEN, J.M., and JUNE, C.H. (1989). CD28 activation pathway regulates the production of multiple T cell-derived lymphokines/cytokines. Proc. Natl. Acad. Sci. USA 86, 1333-1337.
9. AXELSSON, B., YOUSEFFI-ETEMAD, R., HAMMARSTROM, S., and PERLMANN, P. (1988). Induction of aggregation and enhancement of proliferation and IL-2 secretion in human T cells by antibodies to CD43. J. Immunol. 141, 2912-2917.
10. SHJMIZU, Y., VAN SEVENTER, G.A., SIRAGANION, R., WAHL, L., and SHAW, S. (1989). Dual role of the CD44 molecule in T cell adhesion and activation. J. Immunol. 143, 2457-2463.
11. DAVIS, L.S., OPPENHEIMER-MARKS, N., BEDNARCZYK, J.L., McINTYRE, B.W., and LIPSKY, P.E. (1990). Fibronectin promotes proliferation of naive and memory T cells by signaling through both the VLA-4 and VLA-5 integrin molecules. J. Immunol. 145, 785-793.
12. + T cells by the interaction of VLA-4 and VLA-5 with fibronectin or VLA-6 with laminin. J. Immunol. 145, 59-67.
13. VAN SEVENTER, G.A., SHIMIZU, Y., HORGAN, K.J., and SHAW, S. (1990). The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptor-mediated activation of resting T cells. J. Immunol. 144, 4579-4586.
14. TEAGUE, T.K., LAZAROVITS, A.I., and McINTYRE, B.W. (1994). Integrin α4β7 co-stimulation of human peripheral blood T cell proliferation. Cell Adhes. Commun. 2, 539-547.
15. PEARSON, T.C., ALEXANDER, D.Z., WINN, K.J., LINSLEY, P.S., LOWRY, R.P., and LARSEN, C.P. (1994). Transplantation tolerance induced by CTLA-4-lg. Transplantation 57, 1701-1706.
16. ISOBE, M., YAGITA, Y., OKUMURA, K., and IHARA, A. (1992). Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1. Science 225, 1125-1127.
17. COITO, A.J., KOROM, S., GRASER, E., VOLK, H.D., VANDEWATER, L., and KUPIEC-WEGLINKSI, J.W. (1998). Blockade of very late antigen-4 integrin binding to fibronectin in allograft recipients-I. Treatment with connecting segment-1 peptides prevents acute rejection by suppressing intragraft mononuclear cell accumulation, endothelial activation, and cytokine expression. Transplantation 65, 699-706.
18. + T lymphocytes. J. Immunol. 148, 1985-1992.
19. JUNG, T., SCHAUER, U., RIEGER, C., WAGNER, K., EINSLE, K., NEUMANN, C., and HEUSSER, C. (1995). lnterleukin-4 and interleukin-5 are rarely co-expressed by human T cells. Hur. J. Immunol. 25, 2413-2416.
20. HYNES, R.O. (1993). Methods for identification of fibronectins. In: Fibronectins. A. Rich (ed.) New York: Springer-Verlag, p. 12.
21. BEDNARCZYK, J.L., SZABO, M.C., WYGANT, J.N., LAZAROVITS, A.I., and McINTYRE, B.W. (1994). Identification of a combinatorial epitope expressed by the integrin α4β1 heterodimer involved in the regulation of cell adhesion. J. Biol. Chem. 269, 8348-8354.
22. BEDNARCZYK, J.L., WYGANT, J.N., SZABO, M.C., MOLINARI-STOREY, L., RENZ, M., FONG, S., and McINTYRE, B.W. (1993). Homotypic leukocyte aggregation triggered by a monoclonal antibody specific for a novel epitope expressed by the integrin β1 subunit: conversion of nonresponsive cells by transfecting human integrin α4 subunit cDNA. J. Cell. Biochem. 51, 465-478.
23. BEDNARCZYK, J.L., TEAGUE, T.K., WYGANT, J.N., DAVIS, L.S., LIPSKY, P.E., and McINTYRE, B.W. (1992). Regulation of T cell proliferation by anti-CD49d and anti-CD29 monoclonal antibodies. J. Leukocyte Biol. 52, 456-462.
24. CHAMPE, M., McINTYRE, B.W., and BERMAN, P.W. (1995). Monoclonal antibodies that block the activity of leukocyte function-associated antigen 1 recognize three discrete epitopes in the inserted domain of GD11a. J. Biol. Chem. 270, 1388-1394.
25. SZABO, M.C., TEAGUE, T.K., and McINTYRE, B.W. (1995). Regulation of lymphocyte pseudopodia formation by triggering the integrin alpha 4/beta 1. J. Immunol. 154, 2112-2124.
26. WOODSIDE, D.G., TEAGUE, T.K., and McINTYRE, B.W. (1996). Specific inhibition of T lymphocyte coactivation by triggering integrin β1 reveals convergence of β1, β2, and β7 integrin signaling pathways. J. Immunol. 157, 700-706.
27. TEAGUE, T.K., and McINTYRE, B.W. (1994). mAb 18D3 triggering of integrin β1 will prevent but not terminate proliferation of human T cells. Cell Adhes. Commun. 2, 169-184.
28. UDAGAWA, T., and McINTYRE, B.W. (1992). A VLA-4 α-chain specific monoclonal antibody enhances CD3-induced IL-2/IL-2 receptor-dependent T-cell proliferation. Lymphokine Cytokine Res. 11, 193-199.
29. UDAGAWA, T., WOODSIDE, D.G., and McINTYRE, B.W. (1996). α4β1 (CD49d/CD29) integrin costimulation of human T cells enhances transcription factor and cytokine induction in the absence of altered sensitivity to anti-CD3 stimulation. J. Immunol. 157, 1965-1972.
30. YAMADA, A., NIKAIDO, T., NOJIMA, Y., SCHLOSSMAN, S.F., and MORIMOTO, C. (1991). Activation of human CD4 T lymphocytes: interaction of fibronectin with VLA-5 receptor of CD4 cells induces AP-1 transcription factor, J. Immunol. 146, 53-56.
31. MINAMI, Y., KONO, T., MIYAZAKI, T., and TANIGUCHI, T. (1993). The IL-2 receptor complex: its structure, function, and target genes. Annu. Rev. Immunol. 11, 245-267.
32. PICKER, L.J., MANOI, K.S., ZDRAVESKI, Z., TREER, J.R., SHARR, L.W., BERGSTRESSER, P.R., and MAINO, Y.C. (1995). Direct demonstration of cytokine synthesis heterogeneity among human memory/effector T cells by flow cytometry. Blood 4, 1408-1419.
33. VAN SEVENTER, G.A., NEWMAN, W., SHIMUZU, Y., NUTMAN, T.B., TANAKA, Y., MORGAN, K.J., GOPAL, T.V., ENNIS, E., O'SULLIVAN, D., GREY, H., and SHAW, S. (1991). Analysis of T cell stimulation by superantigen plus major histocompatibility complex class II molecules or by CD3 monoclonal antibody: costimulation by purified adhesion ligands VCAM-1, ICAM-1. but not ELAM-1. J. Exp. Med. 174, 901-913.
34. + T cells. J. Exp. Med. 180, 2125-2135.
35. WAYNER, E.A., GARCIA-PARDO, A., HUMPHRIES, M.J., McDONALD, M.J., and CARTER, W.G. (1989). Identification and characterization of the lymphocyte adhesion receptor for an alternative cell attachment domain in plasma fibronectin. J. Cell. Biol. 109, 1321-1330.
36. PYTELA, R., PIERSCHBACHER, M.D., and ROUSLAHI, E. (1985). Identification and isolation of a 140 kd cell surface glycoprotein with properties expected of a fibronectin receptor. Cell 40, 191-198.
37. + T lymphocytes. Proc. Natl. Acad. Sci. USA 88, 6403-6407.
38. LINSLEY, P.S., and LEDBETTER, J.A. (1993). The role of the CD28 receptor during T cell responses to antigen. Annu. Rev. Immunol. 11, 191-212.
39. WALUNAS, T.L., LENSCHOW, D.J., BARKER, C.Y., LINSLEY, P.S., FREEMAN, J.G., THOMPSON, C.B., and BLUESTONE, J.A. (1994). CTLA-4 can function as a negative regulator of T cell activation. Immunity 1, 405-413.
40. KRUMMEL, M.F., and ALLISON, J.P. (1995). CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J. Exp. Med. 182, 459-465.
41. BACHMANN, M.F., McKALL-FAIENZA, K., SCHMIDTS. R., SPEISER, D.E., MAK, T.W., and OHASHI, P.S. (1997). Distinct roles for LFA-1 and CD28 during activation of naive T cells: adhesion versus costimulation. Immunity 7, 549-557.
42. + T cells. J. Exp. Med. 185, 641-651.
43. DUBEY, C., CROFT, M., and SWAIN, S.L. (1996). Naive and effector CD4 T cells differ in their requirements for T cell receptor versus costimulatory signals. J. Immunol. 157, 3280-3289.
44. + T cells. ICAM-1 or B7-1 can costimulate naive CD4 T cell activation but both are required for optimum response. J. Immunol. 155, 45-57.
45. CROFT, M., BRADLEY, L.M., and SWAIN, S.L. (1994). Naive versus memory CD4 T cell responses to antigen. Memory cells are less dependent on accessory cell costimulation and can respond to many antigen-presenting types including resting B cells. J. Immunol. 152, 2675-2685.
46. +) human T cells to multiple receptor-mediated stimuli but augmentation of responses by co-stimuli. Eur. J. Immunol. 20, 1111-1118.
47. BEVERLY, B., RANG, S.M., LENARDO, M.J., and SCHWARTZ, R.H. (1992). Reversal of in vitro T cell clonal anergy by IL-2 stimulation. Int. Immunol. 4, 661-671.
48. YASHIRO, Y., TAI, X.-G., TOYO-OKA, K., PARK, C.-S., ABE, R., HAMAOKA, T., KOBAYASHI, M., NEBEN, S., and FUJI-WARA, H. (1998). A fundamental difference in the capacity to induce proliferation of naive T cells between CD28 and other costimulatory molecules. Eur. J. Immunol. 28, 926-935.
49. FOX. D.A. (1997). The role of T cells in the immunopathogenesis of rheumatoid arthritis: new perspectives. Arthritis Rheum. 4, 598-609.
50. POBER, J.S., and COTRAN, R.S. (1991). Immunologie interactions of T lymphocytes with vascular endothelium. Adv. Immunol. 50, 261-302.
51. SPRENT, J. (1995). Antigen-presenting cells. Professionals and amateurs. Curr. Biol. 5, 1095-1097.
52. - T cells. Eur. J. Immunol. 27, 1082-1090.